Peter Stephen Conti, MD, PhD

Title(s)Professor of Radiology
AddressCSC 103
Health Sciences Campus
Los Angeles CA 90089-9062
Phone+1 323 442 3858
vCardDownload vCard
    Other Positions
    Title(s)Director, Molecular Imaging Center

    Title(s)PET Imaging Center Director


    Collapse Overview 
    Collapse Overview
    Dr. Conti is a tenured Professor at the University of Southern California with academic appointments in the Departments of Radiology, Biomedical Engineering, and Pharmaceutical Sciences. He received his undergraduate degree from Johns Hopkins University and medical degree from Cornell University. His Ph.D. in Biophysics was completed at Memorial Sloan-Kettering Cancer Center. He is board certified in Nuclear Medicine (ABNM) and Diagnostic Radiology (ABR). Dr. Conti has been the Director of the USC PET Imaging Science Center since its inception in 1991. His research activities have focused on the development of novel PET and hybrid imaging agents for diagnostic and theranostic applications in cancer and other diseases. Dr. Conti has published over 300 peer-reviewed papers in the field of molecular imaging. He is the 2016 recipient of the Paul C Aebersold Award from the Society of Nuclear Medicine and Molecular Imaging for his achievements in the basic science of nuclear medicine, and was the 2018 Peter Valk Award recipient for his pioneering work in clinical Positron Emission Tomography. In 2019 he received a Lifetime Achievement Award from the American College of Nuclear Medicine and in January of 2020, the President’s Award for his service to the College. In June 2020, Dr. Conti received the Benedict Cassen Prize from the Education and Research Foundation for his pioneering work in the development of novel radiopharmaceuticals and clinical PET applications for cancer imaging, and his volunteerism and service to the molecular imaging community. The Prize honors the memory of Benedict Cassen, the inventor of the rectilinear radioisotope scanner—the first instrument capable of making an image of radiotracer distribution in body organs of living patients, and was seminal to the development of clinical nuclear medicine.

    Collapse Research 
    Collapse Research Activities and Funding
    IVIS Spectrum Optical Imaging Core Resource
    NIH S10OD021785Apr 15, 2017 - Apr 14, 2020
    Role: Principal Investigator
    Phase Contrast Tomographic X-Ray Microscope System
    NIH S10OD018500Apr 6, 2015 - Apr 5, 2016
    Role: Principal Investigator
    Small Animal Photoacoustic Imaging Unit: Integrating Optical Imaging with High Fr
    NIH S10OD018096Jun 1, 2014 - May 31, 2015
    Role: Principal Investigator
    The Tetrazine Ligation for Efficient 18F Labeling and Pretargeted Imaging/Radiotherapy of Cancer
    NIH R01EB014354Sep 23, 2013 - Jun 30, 2018
    Role: Co-Principal Investigator
    MicroPET/CT for Small Animal Imaging
    NIH S10OD012371Apr 20, 2013 - Apr 19, 2015
    Role: Principal Investigator
    EphB4 as Novel Target for Breast Cancer Imaging
    NIH R21EB012294May 1, 2011 - Apr 30, 2015
    Role: Principal Investigator
    Cyclotron for Molecular Imaging Program at USC
    NIH S10RR029178May 1, 2011 - Apr 30, 2015
    Role: Principal Investigator
    Ultra-High Resolution CT Specimen Scanner for In Vitro Applications
    NIH S10RR027665Jul 1, 2010 - Jun 30, 2011
    Role: Principal Investigator
    Digital X-Ray Device for Molecular Imaging Center
    NIH S10RR027689Jul 1, 2010 - Jun 30, 2011
    Role: Principal Investigator
    High Resolution Ultrasound Resource for Molecular Imaging Center
    NIH S10RR023653May 1, 2007 - Apr 30, 2008
    Role: Principal Investigator
    Micro Computerized Tomography Imaging System
    NIH S10RR019253May 15, 2004 - Dec 30, 2007
    Role: Principal Investigator
    Development of a Cellular and Molecular-Based Cancer Im*
    NIH P20CA086352Jul 12, 2001 - Jun 30, 2007
    Role: Principal Investigator
    SMALL ANIMAL PET SCANNER FOR CANCER APPLICATIONS
    NIH S10RR015703Apr 1, 2001 - Sep 30, 2002
    Role: Principal Investigator
    DUAL HOT CELL SYSTEM AND AUXILLARY EQUIPMENT
    NIH S10RR012966Jul 8, 1998 - Jan 7, 2002
    Role: Principal Investigator
    IN VIVO MARKER OF CELL PROLIFERATION FOR PET STUDIES
    NIH R01CA072896Feb 21, 1997 - Jan 31, 2003
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Required Scholarly Project Mentor

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Exploring Solvent Effects in the Radiosynthesis of 18F-Labeled Thymidine Analogues toward Clinical Translation for Positron Emission Tomography Imaging. ACS Pharmacol Transl Sci. 2021 Feb 12; 4(1):266-275. Li J, Van Valkenburgh J, Conti PS, Chen K. PMID: 33615178.
      View in: PubMed   Mentions:
    2. Associations between Vascular Function and Tau PET Are Associated with Global Cognition and Amyloid. J Neurosci. 2020 10 28; 40(44):8573-8586. Albrecht D, Isenberg AL, Stradford J, Monreal T, Sagare A, Pachicano M, Sweeney M, Toga A, Zlokovic B, Chui H, Joe E, Schneider L, Conti P, Jann K, Pa J. PMID: 33046556.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    3. APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline. Nature. 2020 05; 581(7806):71-76. Montagne A, Nation DA, Sagare AP, Barisano G, Sweeney MD, Chakhoyan A, Pachicano M, Joe E, Nelson AR, D'Orazio LM, Buennagel DP, Harrington MG, Benzinger TLS, Fagan AM, Ringman JM, Schneider LS, Morris JC, Reiman EM, Caselli RJ, Chui HC, Tcw J, Chen Y, Pa J, Conti PS, Law M, Toga AW, Zlokovic BV. PMID: 32376954.
      View in: PubMed   Mentions: 98     Fields:    Translation:HumansCells
    4. Radiofluorinated GPC3-Binding Peptides for PET Imaging of Hepatocellular Carcinoma. Mol Imaging Biol. 2020 02; 22(1):134-143. Li Y, Zhang J, Gu J, Hu K, Huang S, Conti PS, Wu H, Chen K. PMID: 31044341.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    5. A Pre-clinical Animal Model of Secondary Head and Neck Lymphedema. Sci Rep. 2019 12 04; 9(1):18264. Daneshgaran G, Lo AY, Paik CB, Cooper MN, Sung C, Jiao W, Park SY, Ni P, Yu RP, Vorobyova I, Jashashvili T, Hong YK, Kim GH, Conti PS, Chai Y, Wong AK. PMID: 31797883.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    6. Recent advances in the development of nanoparticles for multimodality imaging and therapy of cancer. Med Res Rev. 2020 05; 40(3):909-930. Liu M, Anderson RC, Lan X, Conti PS, Chen K. PMID: 31650619.
      View in: PubMed   Mentions: 3     Fields:    
    7. Small molecules as theranostic agents in cancer immunology. Theranostics. 2019; 9(25):7849-7871. Li J, Van Valkenburgh J, Hong X, Conti PS, Zhang X, Chen K. PMID: 31695804.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimals
    8. PET Imaging of Adenosine Receptors in Diseases. Curr Top Med Chem. 2019; 19(16):1445-1463. Li J, Hong X, Li G, Conti PS, Zhang X, Chen K. PMID: 31284861.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    9. Developing Effective Alzheimer's Disease Therapies: Clinical Experience and Future Directions. J Alzheimers Dis. 2019; 71(3):715-732. Elmaleh DR, Farlow MR, Conti PS, Tompkins RG, Kundakovic L, Tanzi RE. PMID: 31476157.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    10. Polyethyleneimine-Coated Manganese Oxide Nanoparticles for Targeted Tumor PET/MR Imaging. ACS Appl Mater Interfaces. 2018 Oct 17; 10(41):34954-34964. Zhu J, Li H, Xiong Z, Shen M, Conti PS, Shi X, Chen K. PMID: 30234287.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    11. PET imaging of Hsp90 expression in pancreatic cancer using a new 64Cu-labeled dimeric Sansalvamide A decapeptide. Amino Acids. 2018 Jul; 50(7):897-907. Wang X, Zhang J, Wu H, Li Y, Conti PS, Chen K. PMID: 29691700.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    12. 64Cu-Labeled multifunctional dendrimers for targeted tumor PET imaging. Nanoscale. 2018 Mar 29; 10(13):6113-6124. Ma W, Fu F, Zhu J, Huang R, Zhu Y, Liu Z, Wang J, Conti PS, Shi X, Chen K. PMID: 29547220.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    13. Claudin-18-mediated YAP activity regulates lung stem and progenitor cell homeostasis and tumorigenesis. J Clin Invest. 2018 03 01; 128(3):970-984. Zhou B, Flodby P, Luo J, Castillo DR, Liu Y, Yu FX, McConnell A, Varghese B, Li G, Chimge NO, Sunohara M, Koss MN, Elatre W, Conti P, Liebler JM, Yang C, Marconett CN, Laird-Offringa IA, Minoo P, Guan K, Stripp BR, Crandall ED, Borok Z. PMID: 29400695.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansAnimalsCells
    14. Effect of Androgen on Normal Biodistribution of [18F]-2'-Fluoro-5-methyl-1-beta-D-arabinofuranosyluracil (18F-FMAU) in Athymic Non-tumor-bearing Male Mice. Anticancer Res. 2017 02; 37(2):475-479. Jadvar H, Park R, Yap LP, Chen K, Hughes L, Conti P. PMID: 28179292.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    15. A Nanoscale Tool for Photoacoustic-Based Measurements of Clotting Time and Therapeutic Drug Monitoring of Heparin. . 2016 Oct 12; 16(10):6265-6271. Wang J, Chen F, Arconada-Alvarez SJ, Hartanto J, Yap LP, Park R, Wang F, Vorobyova I, Dagliyan G, Conti PS, Jokerst JV. PMID: 27668964.
      View in: PubMed   Mentions:
    16. In Vivo Tumor Angiogenesis Imaging Using Peptide-Based Near-Infrared Fluorescent Probes. Methods Mol Biol. 2016; 1444:73-84. Huang R, Conti PS, Chen K. PMID: 27283419.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    17. A potent immunotoxin targeting fibroblast activation protein for treatment of breast cancer in mice. Int J Cancer. 2016 Feb 15; 138(4):1013-23. Fang J, Xiao L, Joo KI, Liu Y, Zhang C, Liu S, Conti PS, Li Z, Wang P. PMID: 26334777.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansAnimalsCells
    18. A Periodic Diet that Mimics Fasting Promotes Multi-System Regeneration, Enhanced Cognitive Performance, and Healthspan. Cell Metab. 2015 Jul 07; 22(1):86-99. Brandhorst S, Choi IY, Wei M, Cheng CW, Sedrakyan S, Navarrete G, Dubeau L, Yap LP, Park R, Vinciguerra M, Di Biase S, Mirzaei H, Mirisola MG, Childress P, Ji L, Groshen S, Penna F, Odetti P, Perin L, Conti PS, Ikeno Y, Kennedy BK, Cohen P, Morgan TE, Dorff TB, Longo VD. PMID: 26094889.
      View in: PubMed   Mentions: 203     Fields:    Translation:HumansAnimals
    19. Walter Wolf, PhD, 1931-2014. J Nucl Med. 2015 May; 56(5):13N, 18N. Conti PS. PMID: 25934677.
      View in: PubMed   Mentions:    Fields:    
    20. Small-Animal PET Imaging of Pancreatic Cancer Xenografts Using a 64Cu-Labeled Monoclonal Antibody, MAb159. J Nucl Med. 2015 Jun; 56(6):908-13. Wang H, Li D, Liu S, Liu R, Yuan H, Krasnoperov V, Shan H, Conti PS, Gill PS, Li Z. PMID: 25908833.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    21. One-Year Postapproval Clinical Experience with Radium-223 Dichloride in Patients with Metastatic Castrate-Resistant Prostate Cancer. Cancer Biother Radiopharm. 2015 Jun; 30(5):195-9. Jadvar H, Challa S, Quinn DI, Conti PS. PMID: 25746633.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    22. Improved metabolic stability for 18F PET probes rapidly constructed via tetrazine trans-cyclooctene ligation. Bioconjug Chem. 2015 Mar 18; 26(3):435-42. Selvaraj R, Giglio B, Liu S, Wang H, Wang M, Yuan H, Chintala SR, Yap LP, Conti PS, Fox JM, Li Z. PMID: 25679331.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    23. Development of PET probes for cancer imaging. Curr Top Med Chem. 2015; 15(8):795-819. Huang R, Wang M, Zhu Y, Conti PS, Chen K. PMID: 25732787.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimals
    24. Sodium 18F-fluoride PET/CT of bone, joint, and other disorders. Semin Nucl Med. 2015 Jan; 45(1):58-65. Jadvar H, Desai B, Conti PS. PMID: 25475379.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    25. In vivo NIRF imaging-guided delivery of a novel NGR-VEGI fusion protein for targeting tumor vasculature. Amino Acids. 2014 Dec; 46(12):2721-32. Ma W, Li G, Wang J, Yang W, Zhang Y, Conti PS, Chen K. PMID: 25182731.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimals
    26. Characterization and evaluation of (64)Cu-labeled A20FMDV2 conjugates for imaging the integrin avß 6. Mol Imaging Biol. 2014 Aug; 16(4):567-77. Hu LY, Bauer N, Knight LM, Li Z, Liu S, Anderson CJ, Conti PS, Sutcliffe JL. PMID: 24448825.
      View in: PubMed   Mentions: 9     Fields:    Translation:Animals
    27. Axl-targeted cancer imaging with humanized antibody h173. Mol Imaging Biol. 2014 Aug; 16(4):511-8. Li D, Liu S, Liu R, Park R, Yu H, Krasnoperov V, Gill PS, Li Z, Shan H, Conti PS. PMID: 24424460.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    28. MicroPET imaging of CD13 expression using a (64)Cu-labeled dimeric NGR peptide based on sarcophagine cage. Mol Pharm. 2014 Nov 03; 11(11):3938-46. Li G, Wang X, Zong S, Wang J, Conti PS, Chen K. PMID: 25054774.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimalsCells
    29. Integrin a2ß1 targeted GdVO4:Eu ultrathin nanosheet for multimodal PET/MR imaging. Biomaterials. 2014 Oct; 35(30):8649-58. Hu H, Li D, Liu S, Wang M, Moats R, Conti PS, Li Z. PMID: 25043573.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    30. Efficient synthesis of fluorescent-PET probes based on [¹8F]BODIPY dye. Chem Commun (Camb). 2014 Jul 14; 50(55):7371-3. Liu S, Li D, Zhang Z, Surya Prakash GK, Conti PS, Li Z. PMID: 24869927.
      View in: PubMed   Mentions: 11     Fields:    Translation:Animals
    31. Design, synthesis, and validation of Axl-targeted monoclonal antibody probe for microPET imaging in human lung cancer xenograft. Mol Pharm. 2014 Nov 03; 11(11):3974-9. Liu S, Li D, Guo J, Canale N, Li X, Liu R, Krasnoperov V, Gill PS, Conti PS, Shan H, Li Z. PMID: 24978094.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    32. Multimeric disintegrin protein polymer fusions that target tumor vasculature. Biomacromolecules. 2014 Jul 14; 15(7):2347-58. Janib SM, Gustafson JA, Minea RO, Swenson SD, Liu S, Pastuszka MK, Lock LL, Cui H, Markland FS, Conti PS, Li Z, MacKay JA. PMID: 24871936.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    33. (64)Cu labeled sarcophagine exendin-4 for microPET imaging of glucagon like peptide-1 receptor expression. Theranostics. 2014; 4(8):770-7. Wu Z, Liu S, Nair I, Omori K, Scott S, Todorov I, Shively JE, Conti PS, Li Z, Kandeel F. PMID: 24955138.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    34. Facile Preparation of a Thiol-Reactive (18)F-Labeling Agent and Synthesis of (18)F-DEG-VS-NT for PET Imaging of a Neurotensin Receptor-Positive Tumor. J Nucl Med. 2014 Jul; 55(7):1178-84. Wu Z, Li L, Liu S, Yakushijin F, Yakushijin K, Horne D, Conti PS, Li Z, Kandeel F, Shively JE. PMID: 24854793.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    35. The synthesis of lanthanide-doped GdVO4 ultrathin nanosheets with great optical and paramagnetic properties for FRET biodetection and in vivo MR imaging. J Mater Chem B. 2014 Jul 07; 2(25):3998-4007. Hu H, Liu S, Li D, Wang M, Moats R, Shan H, Conti PS, Li Z. PMID: 32261651.
      View in: PubMed   Mentions: 1     Fields:    
    36. Development of multi-functional chelators based on sarcophagine cages. Molecules. 2014 Apr 03; 19(4):4246-55. Liu S, Li Z, Conti PS. PMID: 24705567.
      View in: PubMed   Mentions: 2     Fields:    
    37. Patlak image estimation from dual time-point list-mode PET data. IEEE Trans Med Imaging. 2014 Apr; 33(4):913-24. Zhu W, Li Q, Bai B, Conti PS, Leahy RM. PMID: 24710160.
      View in: PubMed   Mentions: 8     Fields:    
    38. Near-infrared fluorescence imaging of CD13 receptor expression using a novel Cy5.5-labeled dimeric NGR peptide. Amino Acids. 2014 Jun; 46(6):1547-56. Li G, Xing Y, Wang J, Conti PS, Chen K. PMID: 24652439.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    39. A hybrid protein-polymer nanoworm potentiates apoptosis better than a monoclonal antibody. ACS Nano. 2014 Mar 25; 8(3):2064-76. Aluri SR, Shi P, Gustafson JA, Wang W, Lin YA, Cui H, Liu S, Conti PS, Li Z, Hu P, Epstein AL, MacKay JA. PMID: 24484356.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    40. Tumor targeting of a cell penetrating peptide by fusing with a pH-sensitive histidine-glutamate co-oligopeptide. Biomaterials. 2014 Apr; 35(13):4082-7. Fei L, Yap LP, Conti PS, Shen WC, Zaro JL. PMID: 24508076.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    41. Radiolabeled nanoparticles for multimodality tumor imaging. Theranostics. 2014; 4(3):290-306. Xing Y, Zhao J, Conti PS, Chen K. PMID: 24505237.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    42. Functional imaging of human epidermal growth factor receptor 2-positive metastatic breast cancer using (64)Cu-DOTA-trastuzumab PET. J Nucl Med. 2014 Jan; 55(1):23-9. Mortimer JE, Bading JR, Colcher DM, Conti PS, Frankel PH, Carroll MI, Tong S, Poku E, Miles JK, Shively JE, Raubitschek AA. PMID: 24337604.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    43. EphB4-targeted imaging with antibody h131, h131-F(ab')2 and h131-Fab. Mol Pharm. 2013 Dec 02; 10(12):4527-33. Li D, Liu S, Liu R, Zhou Y, Park R, Naga K, Krasnoperov V, Gill PS, Li Z, Shan H, Conti PS. PMID: 24147882.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    44. Sleeve lobectomy for non-small cell lung cancer with N1 nodal disease does not compromise survival. Ann Thorac Surg. 2014 Jan; 97(1):230-5. Berry MF, Worni M, Wang X, Harpole DH, D'Amico TA, Onaitis MW. PMID: 24216681.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    45. Cytoreductive chemotherapy improves the biodistribution of antibodies directed against tumor necrosis in murine solid tumor models. . 2013 Dec; 12(12):2827-36. Jang JK, Khawli LA, Park R, Wu BW, Li Z, Canter D, Conti PS, Epstein AL. PMID: 24130055.
      View in: PubMed   Mentions:
    46. Evaluation of ¹8F-labeled BODIPY dye as potential PET agents for myocardial perfusion imaging. Nucl Med Biol. 2014 Jan; 41(1):120-6. Liu S, Li D, Shan H, Gabbaï FP, Li Z, Conti PS. PMID: 24210284.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    47. Tumor quantification in clinical positron emission tomography. Theranostics. 2013 Oct 07; 3(10):787-801. Bai B, Bading J, Conti PS. PMID: 24312151.
      View in: PubMed   Mentions: 41     Fields:    
    48. Monoclonal antibody against cell surface GRP78 as a novel agent in suppressing PI3K/AKT signaling, tumor growth, and metastasis. Clin Cancer Res. 2013 Dec 15; 19(24):6802-11. Liu R, Li X, Gao W, Zhou Y, Wey S, Mitra SK, Krasnoperov V, Dong D, Liu S, Li D, Zhu G, Louie S, Conti PS, Li Z, Lee AS, Gill PS. PMID: 24048331.
      View in: PubMed   Mentions: 64     Fields:    Translation:HumansAnimalsCells
    49. Urokinase plasminogen activator receptor (uPAR) targeted nuclear imaging and radionuclide therapy. Theranostics. 2013; 3(7):507-15. Li D, Liu S, Shan H, Conti P, Li Z. PMID: 23843898.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimals
    50. Baseline 18F-FDG PET/CT parameters as imaging biomarkers of overall survival in castrate-resistant metastatic prostate cancer. J Nucl Med. 2013 Aug; 54(8):1195-201. Jadvar H, Desai B, Ji L, Conti PS, Dorff TB, Groshen SG, Pinski JK, Quinn DI. PMID: 23785174.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCTClinical Trials
    51. PET imaging of colorectal and breast cancer by targeting EphB4 receptor with 64Cu-labeled hAb47 and hAb131 antibodies. J Nucl Med. 2013 Jul; 54(7):1094-100. Liu S, Li D, Park R, Liu R, Xia Z, Guo J, Krasnoperov V, Gill PS, Li Z, Shan H, Conti PS. PMID: 23667241.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimalsCells
    52. Efficient 18F labeling of cysteine-containing peptides and proteins using tetrazine-trans-cyclooctene ligation. Mol Imaging. 2013 Mar-Apr; 12(2):121-8. Liu S, Hassink M, Selvaraj R, Yap LP, Park R, Wang H, Chen X, Fox JM, Li Z, Conti PS. PMID: 23415400.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    53. Lewis acid-assisted isotopic 18F-19F exchange in BODIPY dyes: facile generation of positron emission tomography/fluorescence dual modality agents for tumor imaging. Theranostics. 2013; 3(3):181-9. Liu S, Lin TP, Li D, Leamer L, Shan H, Li Z, Gabbaï FP, Conti PS. PMID: 23471211.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    54. RGD-based PET tracers for imaging receptor integrin av ß3 expression. J Labelled Comp Radiopharm. 2013 May 15; 56(5):264-79. Cai H, Conti PS. PMID: 24285371.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimals
    55. Crosslinked multilamellar liposomes for controlled delivery of anticancer drugs. Biomaterials. 2013 Apr; 34(12):3098-109. Joo KI, Xiao L, Liu S, Liu Y, Lee CL, Conti PS, Wong MK, Li Z, Wang P. PMID: 23375392.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansAnimalsCells
    56. Development and evaluation of 18F-TTCO-Cys40-Exendin-4: a PET probe for imaging transplanted islets. J Nucl Med. 2013 Feb; 54(2):244-51. Wu Z, Liu S, Hassink M, Nair I, Park R, Li L, Todorov I, Fox JM, Li Z, Shively JE, Conti PS, Kandeel F. PMID: 23297075.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansAnimalsCells
    57. "Kit like" (18)F labeling method for synthesis of RGD peptide-based PET probes. Am J Nucl Med Mol Imaging. 2013; 3(1):97-101. Liu S, Park R, Conti PS, Li Z. PMID: 23342304.
      View in: PubMed   Mentions:
    58. Targeting the EphB4 receptor for cancer diagnosis and therapy monitoring. Mol Pharm. 2013 Jan 07; 10(1):329-36. Li D, Liu S, Liu R, Park R, Hughes L, Krasnoperov V, Gill PS, Li Z, Shan H, Conti PS. PMID: 23211050.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    59. Synthesis and evaluation of 64Cu-labeled monomeric and dimeric NGR peptides for MicroPET imaging of CD13 receptor expression. Mol Pharm. 2013 Jan 07; 10(1):417-27. Chen K, Ma W, Li G, Wang J, Yang W, Yap LP, Hughes LD, Park R, Conti PS. PMID: 23190134.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimalsCells
    60. Efficient construction of PET/fluorescence probe based on sarcophagine cage: an opportunity to integrate diagnosis with treatment. Mol Imaging Biol. 2012 Dec; 14(6):718-24. Liu S, Li D, Huang CW, Yap LP, Park R, Shan H, Li Z, Conti PS. PMID: 22476968.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    61. Radioactive smart probe for potential corrected matrix metalloproteinase imaging. Bioconjug Chem. 2012 Nov 21; 23(11):2159-67. Huang CW, Li Z, Conti PS. PMID: 23025637.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    62. Strain-Promoted Catalyst-Free Click Chemistry for Rapid Construction of (64)Cu-Labeled PET Imaging Probes. ACS Med Chem Lett. 2012 Dec 13; 3(12):1019-23. Chen K, Wang X, Lin WY, Shen CK, Yap LP, Hughes LD, Conti PS. PMID: 24900423.
      View in: PubMed   Mentions:
    63. Fasting enhances the response of glioma to chemo- and radiotherapy. PLoS One. 2012; 7(9):e44603. Safdie F, Brandhorst S, Wei M, Wang W, Lee C, Hwang S, Conti PS, Chen TC, Longo VD. PMID: 22984531.
      View in: PubMed   Mentions: 64     Fields:    Translation:AnimalsCells
    64. [18F]-2'-Fluoro-5-methyl-1-beta-D-arabinofuranosyluracil (18F-FMAU) in prostate cancer: initial preclinical observations. Mol Imaging. 2012 Sep-Oct; 11(5):426-32. Jadvar H, Yap LP, Park R, Li Z, Chen K, Hughes L, Kouhi A, Conti P. PMID: 22954187.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    65. Induced T regulatory cells suppress osteoclastogenesis and bone erosion in collagen-induced arthritis better than natural T regulatory cells. Ann Rheum Dis. 2012 Sep; 71(9):1567-1572. Kong N, Lan Q, Su W, Chen M, Wang J, Yang Z, Park R, Dagliyan G, Conti PS, Brand D, Liu Z, Stohl W, Zou H, Zheng SG. PMID: 22764040.
      View in: PubMed   Mentions: 45     Fields:    Translation:AnimalsCells
    66. ß-adrenergic receptor inhibition affects cerebral glucose metabolism, motor performance, and inflammatory response after traumatic brain injury. J Trauma Acute Care Surg. 2012 Jul; 73(1):33-40. Ley EJ, Clond MA, Bukur M, Park R, Chervonski M, Dagliyan G, Margulies DR, Lyden PD, Conti PS, Salim A. PMID: 22743370.
      View in: PubMed   Mentions: 11     Fields:    Translation:Animals
    67. Prospective evaluation of 18F-NaF and 18F-FDG PET/CT in detection of occult metastatic disease in biochemical recurrence of prostate cancer. Clin Nucl Med. 2012 Jul; 37(7):637-43. Jadvar H, Desai B, Ji L, Conti PS, Dorff TB, Groshen SG, Gross ME, Pinski JK, Quinn DI. PMID: 22691503.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCTClinical Trials
    68. The efficient synthesis and biological evaluation of novel bi-functionalized sarcophagine for (64)cu radiopharmaceuticals. Theranostics. 2012; 2(6):589-96. Liu S, Li D, Huang CW, Yap LP, Park R, Shan H, Li Z, Conti PS. PMID: 22737194.
      View in: PubMed   Mentions: 9     Fields:    
    69. Quantitative, simultaneous PET/MRI for intratumoral imaging with an MRI-compatible PET scanner. J Nucl Med. 2012 Jul; 53(7):1102-9. Ng TS, Bading JR, Park R, Sohi H, Procissi D, Colcher D, Conti PS, Cherry SR, Raubitschek AA, Jacobs RE. PMID: 22661534.
      View in: PubMed   Mentions: 9     Fields:    Translation:Animals
    70. Microwave-assisted one-pot radiosynthesis of 2'-deoxy-2'-[18F]fluoro-5-methyl-1-ß-d-arabinofuranosyluracil ([18F]-FMAU). Nucl Med Biol. 2012 Oct; 39(7):1019-25. Chen K, Li Z, Conti PS. PMID: 22503457.
      View in: PubMed   Mentions: 2     Fields:    
    71. Evaluation of 64Cu labeled GX1: a phage display peptide probe for PET imaging of tumor vasculature. Mol Imaging Biol. 2012 Feb; 14(1):96-105. Chen K, Sun X, Niu G, Ma Y, Yap LP, Hui X, Wu K, Fan D, Conti PS, Chen X. PMID: 21360213.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimalsCells
    72. A potentially common peptide target in secreted heat shock protein-90a for hypoxia-inducible factor-1a-positive tumors. Mol Biol Cell. 2012 Feb; 23(4):602-13. Sahu D, Zhao Z, Tsen F, Cheng CF, Park R, Situ AJ, Dai J, Eginli A, Shams S, Chen M, Ulmer TS, Conti P, Woodley DT, Li W. PMID: 22190738.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansAnimalsCells
    73. PET imaging of metabotropic glutamate receptor subtype 5 (mGluR5). Am J Nucl Med Mol Imaging. 2012; 2(1):29-32. Li D, Shan H, Conti P, Li Z. PMID: 23133800.
      View in: PubMed   Mentions:
    74. Trackable and Targeted Phage as Positron Emission Tomography (PET) Agent for Cancer Imaging. Theranostics. 2011; 1:371-80. Li Z, Jin Q, Huang C, Dasa S, Chen L, Yap LP, Liu S, Cai H, Park R, Conti PS. PMID: 22211143.
      View in: PubMed   Mentions: 15     Fields:    
    75. In vivo near-infrared fluorescence imaging of integrin a2ß1 in prostate cancer with cell-penetrating-peptide-conjugated DGEA probe. J Nucl Med. 2011 Dec; 52(12):1979-86. Huang CW, Li Z, Conti PS. PMID: 22065876.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    76. Efficient preparation and biological evaluation of a novel multivalency bifunctional chelator for 64Cu radiopharmaceuticals. Chemistry. 2011 Sep 05; 17(37):10222-5. Liu S, Li Z, Yap LP, Huang CW, Park R, Conti PS. PMID: 21815227.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    77. Rapid aqueous [18F]-labeling of a bodipy dye for positron emission tomography/fluorescence dual modality imaging. Chem Commun (Camb). 2011 Sep 07; 47(33):9324-6. Li Z, Lin TP, Liu S, Huang CW, Hudnall TW, Gabbaï FP, Conti PS. PMID: 21779546.
      View in: PubMed   Mentions: 19     Fields:    Translation:Animals
    78. SNM clinical trials network validates 100th scanner. J Nucl Med. 2011 Jun; 52(6):25N. Graham M, Conti P, Hoffman J. PMID: 21622892.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    79. Tetrazine-trans-cyclooctene ligation for the rapid construction of integrin avß3 targeted PET tracer based on a cyclic RGD peptide. Bioorg Med Chem Lett. 2011 Sep 01; 21(17):5011-4. Selvaraj R, Liu S, Hassink M, Huang CW, Yap LP, Park R, Fox JM, Li Z, Conti PS. PMID: 21601452.
      View in: PubMed   Mentions: 35     Fields:    Translation:AnimalsCells
    80. 18F-5-fluorouracil dynamic positron emission tomography/computed tomography shows decreased tracer activity after bevacizumab in colorectal metastases. Nucl Med Commun. 2011 May; 32(5):343-7. Zissen MH, Kunz P, Subbarayan M, Chin FT, Conti PS, Fisher GA, Quon A. PMID: 21412178.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    81. Novel a(2)ß(1) integrin-targeted peptide probes for prostate cancer imaging. Mol Imaging. 2011 Aug; 10(4):284-94. Huang CW, Li Z, Cai H, Shahinian T, Conti PS. PMID: 21486537.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    82. The improved syntheses of 5-substituted 2'-[18F]fluoro-2'-deoxy-arabinofuranosyluracil derivatives ([18F]FAU, [18F]FEAU, [18F]FFAU, [18F]FCAU, [18F]FBAU and [18F]FIAU) using a multistep one-pot strategy. Nucl Med Biol. 2011 Jul; 38(5):659-66. Cai H, Li Z, Conti PS. PMID: 21718941.
      View in: PubMed   Mentions: 9     Fields:    
    83. Design, synthesis and validation of integrin a2ß1-targeted probe for microPET imaging of prostate cancer. Eur J Nucl Med Mol Imaging. 2011 Jul; 38(7):1313-22. Huang CW, Li Z, Cai H, Chen K, Shahinian T, Conti PS. PMID: 21350963.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    84. Biological stability evaluation of the a2ß1 receptor imaging agents: diamsar and DOTA conjugated DGEA peptide. Bioconjug Chem. 2011 Feb 16; 22(2):256-63. Huang CW, Li Z, Cai H, Shahinian T, Conti PS. PMID: 21244039.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    85. A Cy5.5-labeled phage-displayed peptide probe for near-infrared fluorescence imaging of tumor vasculature in living mice. Amino Acids. 2012 Apr; 42(4):1329-37. Chen K, Yap LP, Park R, Hui X, Wu K, Fan D, Chen X, Conti PS. PMID: 21212998.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimalsCells
    86. Compliance with PET acquisition protocols for therapeutic monitoring of erlotinib therapy in an international trial for patients with non-small cell lung cancer. Eur J Nucl Med Mol Imaging. 2011 Apr; 38(4):642-50. Binns DS, Pirzkall A, Yu W, Callahan J, Mileshkin L, Conti P, Scott AM, Macfarlane D, Fine BM, Hicks RJ, OSI3926g Study Team . PMID: 21207024.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    87. (64)Cu labeled AmBaSar-RGD2 for micro-PET imaging of integrin avß3 expression. Curr Radiopharm. 2011 Jan; 4(1):68-74. Cai H, Li Z, Huang CW, Park R, Conti PS. PMID: 22191616.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    88. Improved synthesis of 2'-deoxy-2'-[18F]fluoro-5-methyl-1-ß-D-arabinofuranosyluracil ([18F]FMAU). Curr Radiopharm. 2011 Jan; 4(1):24-30. Li Z, Cai H, Conti PS. PMID: 22191612.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    89. Automated synthesis of 2'-deoxy-2'-[18F]fluoro-5-methyl-1-ß-D-arabinofuranosyluracil ([18F]-FMAU) using a one reactor radiosynthesis module. Nucl Med Biol. 2011 Feb; 38(2):201-6. Li Z, Cai H, Conti PS. PMID: 21315275.
      View in: PubMed   Mentions: 11     Fields:    
    90. Clinical trials network strives for standardization. J Nucl Med. 2010 Nov; 51(11):15N. Graham M, Conti P, Hoffman J. PMID: 21051645.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    91. Tetrazine-trans-cyclooctene ligation for the rapid construction of 18F labeled probes. Chem Commun (Camb). 2010 Nov 14; 46(42):8043-5. Li Z, Cai H, Hassink M, Blackman ML, Brown RC, Conti PS, Fox JM. PMID: 20862423.
      View in: PubMed   Mentions: 58     Fields:    
    92. Radiopharmaceutical chemistry for positron emission tomography. Adv Drug Deliv Rev. 2010 Aug 30; 62(11):1031-51. Li Z, Conti PS. PMID: 20854860.
      View in: PubMed   Mentions: 33     Fields:    Translation:Cells
    93. Target-specific delivery of peptide-based probes for PET imaging. Adv Drug Deliv Rev. 2010 Aug 30; 62(11):1005-22. Chen K, Conti PS. PMID: 20851156.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansAnimals
    94. Evaluation of copper-64 labeled AmBaSar conjugated cyclic RGD peptide for improved microPET imaging of integrin alphavbeta3 expression. Bioconjug Chem. 2010 Aug 18; 21(8):1417-24. Cai H, Li Z, Huang CW, Shahinian AH, Wang H, Park R, Conti PS. PMID: 20666401.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansAnimalsCells
    95. The sodium bicarbonate cotransporter (NBCe1) is essential for normal development of mouse dentition. J Biol Chem. 2010 Aug 06; 285(32):24432-8. Lacruz RS, Nanci A, White SN, Wen X, Wang H, Zalzal SF, Luong VQ, Schuetter VL, Conti PS, Kurtz I, Paine ML. PMID: 20529845.
      View in: PubMed   Mentions: 44     Fields:    Translation:Animals
    96. In vivo effect of propranolol dose and timing on cerebral perfusion after traumatic brain injury. J Trauma. 2010 Feb; 68(2):353-6. Ley EJ, Park R, Dagliyan G, Palestrant D, Miller CM, Conti PS, Margulies DR, Salim A. PMID: 20154548.
      View in: PubMed   Mentions: 7     Fields:    Translation:Animals
    97. An improved synthesis and biological evaluation of a new cage-like bifunctional chelator, 4-((8-amino-3,6,10,13,16,19-hexaazabicyclo[6.6.6]icosane-1-ylamino)methyl)benzoic acid, for 64Cu radiopharmaceuticals. Nucl Med Biol. 2010 Jan; 37(1):57-65. Cai H, Li Z, Huang CW, Park R, Shahinian AH, Conti PS. PMID: 20122669.
      View in: PubMed   Mentions: 17     Fields:    Translation:Animals
    98. Controlling familywise error rate for matched subspace detection in dynamic FDG PET. IEEE Trans Med Imaging. 2009 Oct; 28(10):1623-31. Li Z, Li Q, Pantazis D, Yu X, Conti PS, Leahy RM. PMID: 19783499.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    99. Site qualification in multicenter clinical trials. J Nucl Med. 2009 Aug; 50(8):30N. McEwan AS, Graham MM, Conti PS. PMID: 19652215.
      View in: PubMed   Mentions: 1     Fields:    
    100. Synthesis of a novel bifunctional chelator AmBaSar based on sarcophagine for peptide conjugation and (64)Cu radiolabelling. Dalton Trans. 2009 Jul 21; (27):5395-400. Cai H, Fissekis J, Conti PS. PMID: 19565091.
      View in: PubMed   Mentions: 17     Fields:    
    101. SNM molecular imaging summit introduces clinical trials network. J Nucl Med. 2009 Apr; 50(4):18N. McEwan AS, Graham MM, Conti PS. PMID: 19339670.
      View in: PubMed   Mentions: 1     Fields:    
    102. Lesion detection in dynamic FDG-PET using matched subspace detection. IEEE Trans Med Imaging. 2009 Feb; 28(2):230-40. Li Z, Li Q, Yu X, Conti PS, Leahy RM. PMID: 19188110.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    103. New directions in the therapeutic strategy to improve survival outcomes in patients with non-Hodgkin's lymphoma. Introduction. Oncologist. 2009; 14 Suppl 2:1-3. Bischof Delaloye A, Conti PS, Gisselbrecht C, Gregory SA. PMID: 19819919.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    104. New directions in the therapeutic strategy to improve survival outcomes in patients with non-Hodgkin's lymphoma. Summary. Oncologist. 2009; 14 Suppl 2:52-4. Bischof Delaloye A, Conti PS, Gisselbrecht C, Gregory SA. PMID: 19819924.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    105. The in vivo effect of propranolol on cerebral perfusion and hypoxia after traumatic brain injury. J Trauma. 2009 Jan; 66(1):154-9; discussion 159-61. Ley EJ, Scehnet J, Park R, Schroff S, Dagliyan G, Conti PS, Margulies DR, Salim A. PMID: 19131818.
      View in: PubMed   Mentions: 17     Fields:    Translation:Animals
    106. Expert opinions on positron emission tomography and computed tomography imaging in lymphoma. Oncologist. 2009; 14 Suppl 2:30-40. Delbeke D, Stroobants S, de Kerviler E, Gisselbrecht C, Meignan M, Conti PS. PMID: 19819922.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    107. [F-18]-fluorodeoxyglucose PET-CT of the normal prostate gland. Ann Nucl Med. 2008 Nov; 22(9):787-93. Jadvar H, Ye W, Groshen S, Conti PS. PMID: 19039557.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    108. Biglycan overexpression on tooth enamel formation in transgenic mice. Anat Rec (Hoboken). 2008 Oct; 291(10):1246-53. Wen X, Zou Y, Luo W, Goldberg M, Moats R, Conti PS, Snead ML, Paine ML. PMID: 18727043.
      View in: PubMed   Mentions: 8     Fields:    Translation:AnimalsCells
    109. Molecular imaging: the future of modern medicine. J Nucl Med. 2008 Jun; 49(6):16N-20N. Conti PS, McEwan AJ, Pomper MG. PMID: 18511813.
      View in: PubMed   Mentions:    Fields:    
    110. Choline autoradiography of human prostate cancer xenograft: effect of castration. Mol Imaging. 2008 May-Jun; 7(3):147-52. Jadvar H, Gurbuz A, Li X, Shahinian A, Conti PS. PMID: 19123985.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    111. [F-18]-Fluorodeoxyglucose PET and PET-CT in diagnostic imaging evaluation of locally recurrent and metastatic bladder transitional cell carcinoma. Int J Clin Oncol. 2008 Feb; 13(1):42-7. Jadvar H, Quan V, Henderson RW, Conti PS. PMID: 18307018.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    112. B-cell non-Hodgkin lymphoma: PET/CT evaluation after 90Y-ibritumomab tiuxetan radioimmunotherapy--initial experience. Radiology. 2008 Mar; 246(3):895-902. Ulaner GA, Colletti PM, Conti PS. PMID: 18258810.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    113. F-18 FDG PET and PET/CT evaluation of response to chemotherapy in bone and soft tissue sarcomas. Clin Nucl Med. 2008 Jan; 33(1):8-13. Iagaru A, Masamed R, Chawla SP, Menendez LR, Fedenko A, Conti PS. PMID: 18097248.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    114. In vivo measurement of cell proliferation in canine brain tumor using C-11-labeled FMAU and PET. Nucl Med Biol. 2008 Jan; 35(1):131-41. Conti PS, Bading JR, Mouton PP, Links JM, Alauddin MM, Fissekis JD, Ravert HT, Hilton J, Wong DF, Anderson JH. PMID: 18158952.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    115. Weight-based dosing of Yttrium 90 ibritumomab tiuxetan in patients with relapsed or refractory B-cell non-Hodgkin lymphoma. Clin Lymphoma Myeloma. 2007 Sep; 7(8):514-7. Wiseman GA, Conti PS, Vo K, Schilder RJ, Gordon LI, Emmanouilides C, Silverman DH, Witzig TE, Darif M, Molina A. PMID: 18021468.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    116. Mouse models of prostate adenocarcinoma with the capacity to monitor spontaneous carcinogenesis by bioluminescence or fluorescence. Cancer Res. 2007 Aug 01; 67(15):7525-33. Liao CP, Zhong C, Saribekyan G, Bading J, Park R, Conti PS, Moats R, Berns A, Shi W, Zhou Z, Nikitin AY, Roy-Burman P. PMID: 17671224.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansAnimalsCells
    117. Detection of occult medullary thyroid cancer recurrence with 2-deoxy-2-[F-18]fluoro-D-glucose-PET and PET/CT. Mol Imaging Biol. 2007 Mar-Apr; 9(2):72-7. Iagaru A, Masamed R, Singer PA, Conti PS. PMID: 17186139.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    118. [F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma. J Comput Assist Tomogr. 2007 Mar-Apr; 31(2):223-8. Jadvar H, Henderson RW, Conti PS. PMID: 17414758.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    119. Biodistribution and PET imaging of [(18)F]-fluoroadenosine derivatives. Nucl Med Biol. 2007 Apr; 34(3):267-72. Alauddin MM, Shahinian A, Park R, Tohme M, Fissekis JD, Conti PS. PMID: 17383576.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    120. In vivo evaluation of 2'-deoxy-2'-[(18)F]fluoro-5-iodo-1-beta-D-arabinofuranosyluracil ([18F]FIAU) and 2'-deoxy-2'-[18F]fluoro-5-ethyl-1-beta-D-arabinofuranosyluracil ([18F]FEAU) as markers for suicide gene expression. Eur J Nucl Med Mol Imaging. 2007 Jun; 34(6):822-9. Alauddin MM, Shahinian A, Park R, Tohme M, Fissekis JD, Conti PS. PMID: 17206416.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimals
    121. Breast MRI and 18F FDG PET/CT in the management of breast cancer. Ann Nucl Med. 2007 Jan; 21(1):33-8. Iagaru A, Masamed R, Keesara S, Conti PS. PMID: 17373334.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    122. 18F-FDG PET and PET/CT for detection of pulmonary metastases from musculoskeletal sarcomas. Nucl Med Commun. 2006 Oct; 27(10):795-802. Iagaru A, Chawla S, Menendez L, Conti PS. PMID: 16969262.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    123. 2-Deoxy-2-[18F]fluoro-D-glucose-positron emission tomography and positron emission tomography/computed tomography diagnosis of patients with recurrent papillary thyroid cancer. Mol Imaging Biol. 2006 Sep-Oct; 8(5):309-14. Iagaru A, Masamed R, Singer PA, Conti PS. PMID: 16758370.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    124. Smad3 deficiency promotes tumorigenesis in the distal colon of ApcMin/+ mice. Cancer Res. 2006 Sep 01; 66(17):8430-8. Sodir NM, Chen X, Park R, Nickel AE, Conti PS, Moats R, Bading JR, Shibata D, Laird PW. PMID: 16951153.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansAnimalsCells
    125. 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography/computed tomography imaging evaluation of esophageal cancer. Mol Imaging Biol. 2006 May-Jun; 8(3):193-200. Jadvar H, Henderson RW, Conti PS. PMID: 16565910.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    126. Longitudinal microPET imaging of brain tumor growth with F-18-labeled RGD peptide. Mol Imaging Biol. 2006 Jan-Feb; 8(1):9-15. Chen X, Park R, Khankaldyyan V, Gonzales-Gomez I, Tohme M, Moats RA, Bading JR, Laug WE, Conti PS. PMID: 16315003.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    127. Hyperspectral and multispectral bioluminescence optical tomography for small animal imaging. Phys Med Biol. 2005 Dec 07; 50(23):5421-41. Chaudhari AJ, Darvas F, Bading JR, Moats RA, Conti PS, Smith DJ, Cherry SR, Leahy RM. PMID: 16306643.
      View in: PubMed   Mentions: 72     Fields:    Translation:HumansAnimalsCells
    128. The role of imaging with (111)In-ibritumomab tiuxetan in the ibritumomab tiuxetan (zevalin) regimen: results from a Zevalin Imaging Registry. J Nucl Med. 2005 Nov; 46(11):1812-8. Conti PS, White C, Pieslor P, Molina A, Aussie J, Foster P. PMID: 16269594.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    129. Concurrent PET/CT with an integrated imaging system: intersociety dialogue from the Joint Working Group of the American College of Radiology, the Society of Nuclear Medicine, and the Society of Computed Body Tomography and Magnetic Resonance. J Am Coll Radiol. 2005 Jul; 2(7):568-84. Coleman RE, Delbeke D, Guiberteau MJ, Conti PS, Royal HD, Weinreb JC, Siegel BA, Federle MP, Townsend DW, Berland LL, Joint Working Group of the American College of Radiology , Society of Nuclear Medicine , Society of Computed Body Tomography and Magnetic Resonance . PMID: 17411882.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    130. Concurrent PET/CT with an integrated imaging system: intersociety dialogue from the joint working group of the American College of Radiology, the Society of Nuclear Medicine, and the Society of Computed Body Tomography and Magnetic Resonance. J Nucl Med. 2005 Jul; 46(7):1225-39. Coleman RE, Delbeke D, Guiberteau MJ, Conti PS, Royal HD, Weinreb JC, Siegel BA, Federle MF, Townsend DW, Berland LL, American College of Radiology , Society of Nuclear Medicine , Society of Computed Body Tomography and Magnetic Resonance . PMID: 16000293.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    131. Glucose metabolism of human prostate cancer mouse xenografts. Mol Imaging. 2005 Apr-Jun; 4(2):91-7. Jadvar H, Xiankui L, Shahinian A, Park R, Tohme M, Pinski J, Conti PS. PMID: 16105512.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansAnimals
    132. Integrin alpha v beta 3-targeted imaging of lung cancer. Neoplasia. 2005 Mar; 7(3):271-9. Chen X, Sievers E, Hou Y, Park R, Tohme M, Bart R, Bremner R, Bading JR, Conti PS. PMID: 15799827.
      View in: PubMed   Mentions: 58     Fields:    Translation:HumansAnimalsCells
    133. The future of radioimmunotherapy: a PET perspective. Semin Oncol. 2005 Feb; 32(1 Suppl 1):S63-7. Conti PS. PMID: 15786028.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    134. Synthesis and evaluation of 2'-deoxy-2'-18F-fluoro-5-fluoro-1-beta-D-arabinofuranosyluracil as a potential PET imaging agent for suicide gene expression. J Nucl Med. 2004 Dec; 45(12):2063-9. Alauddin MM, Shahinian A, Park R, Tohme M, Fissekis JD, Conti PS. PMID: 15585483.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    135. Virchow's node on F-18 FDG PET/CT. Clin Nucl Med. 2004 Nov; 29(11):770-2. Cham D, Henderson R, Conti PS. PMID: 15483511.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    136. In vivo near-infrared fluorescence imaging of integrin alphavbeta3 in brain tumor xenografts. Cancer Res. 2004 Nov 01; 64(21):8009-14. Chen X, Conti PS, Moats RA. PMID: 15520209.
      View in: PubMed   Mentions: 101     Fields:    Translation:HumansAnimalsCells
    137. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression. J Nucl Med. 2004 Oct; 45(10):1776-83. Chen X, Hou Y, Tohme M, Park R, Khankaldyyan V, Gonzales-Gomez I, Bading JR, Laug WE, Conti PS. PMID: 15471848.
      View in: PubMed   Mentions: 85     Fields:    Translation:Animals
    138. The reproductive tract. Semin Nucl Med. 2004 Oct; 34(4):262-73. Jadvar H, Conti PS. PMID: 15493004.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    139. Musculoskeletal system. Semin Nucl Med. 2004 Oct; 34(4):254-61. Jadvar H, Gamie S, Ramanna L, Conti PS. PMID: 15493003.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    140. MicroPET imaging of breast cancer alphav-integrin expression with 64Cu-labeled dimeric RGD peptides. Mol Imaging Biol. 2004 Sep-Oct; 6(5):350-9. Chen X, Liu S, Hou Y, Tohme M, Park R, Bading JR, Conti PS. PMID: 15380745.
      View in: PubMed   Mentions: 89     Fields:    Translation:HumansAnimalsCells
    141. microPET and autoradiographic imaging of GRP receptor expression with 64Cu-DOTA-[Lys3]bombesin in human prostate adenocarcinoma xenografts. J Nucl Med. 2004 Aug; 45(8):1390-7. Chen X, Park R, Hou Y, Tohme M, Shahinian AH, Bading JR, Conti PS. PMID: 15299066.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansAnimals
    142. Synthesis of 2'-deoxy-2'-[18F]fluoro-5-bromo-1-beta-D-arabinofuranosyluracil ([18F]-FBAU) and 2'-deoxy-2'-[18F]fluoro-5-chloro-1-beta-D-arabinofuranosyl-uracil ([18F]-FCAU), and their biological evaluation as markers for gene expression. Nucl Med Biol. 2004 May; 31(4):399-405. Alauddin MM, Shahinian A, Park R, Tohme M, Fissekis JD, Conti PS. PMID: 15093809.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimals
    143. Pharmacokinetics of the thymidine analog 2'-fluoro-5-methyl-1-beta-D-arabinofuranosyluracil (FMAU) in tumor-bearing rats. Nucl Med Biol. 2004 May; 31(4):407-18. Bading JR, Shahinian AH, Vail A, Bathija P, Koszalka GW, Koda RT, Alauddin MM, Fissekis JD, Conti PS. PMID: 15093810.
      View in: PubMed   Mentions: 11     Fields:    Translation:AnimalsCells
    144. MicroPET imaging of brain tumor angiogenesis with 18F-labeled PEGylated RGD peptide. Eur J Nucl Med Mol Imaging. 2004 Aug; 31(8):1081-9. Chen X, Park R, Hou Y, Khankaldyyan V, Gonzales-Gomez I, Tohme M, Bading JR, Laug WE, Conti PS. PMID: 15118844.
      View in: PubMed   Mentions: 43     Fields:    Translation:Animals
    145. Micro-PET imaging of alphavbeta3-integrin expression with 18F-labeled dimeric RGD peptide. Mol Imaging. 2004 Apr; 3(2):96-104. Chen X, Tohme M, Park R, Hou Y, Bading JR, Conti PS. PMID: 15296674.
      View in: PubMed   Mentions: 64     Fields:    Translation:HumansAnimalsCells
    146. Direct comparison of radiolabeled probes FMAU, FHBG, and FHPG as PET imaging agents for HSV1-tk expression in a human breast cancer model. Mol Imaging. 2004 Apr; 3(2):76-84. Alauddin MM, Shahinian A, Gordon EM, Conti PS. PMID: 15296672.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansAnimalsCells
    147. 18F-labeled RGD peptide: initial evaluation for imaging brain tumor angiogenesis. Nucl Med Biol. 2004 Feb; 31(2):179-89. Chen X, Park R, Shahinian AH, Tohme M, Khankaldyyan V, Bozorgzadeh MH, Bading JR, Moats R, Laug WE, Conti PS. PMID: 15013483.
      View in: PubMed   Mentions: 72     Fields:    Translation:HumansAnimalsCells
    148. Radioimmunotherapy with yttrium 90 ibritumomab tiuxetan (Zevalin): the role of the nuclear medicine physician. Semin Nucl Med. 2004 Jan; 34(1 Suppl 1):2-3. Conti PS. PMID: 14762737.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    149. MicroPET and autoradiographic imaging of breast cancer alpha v-integrin expression using 18F- and 64Cu-labeled RGD peptide. Bioconjug Chem. 2004 Jan-Feb; 15(1):41-9. Chen X, Park R, Tohme M, Shahinian AH, Bading JR, Conti PS. PMID: 14733582.
      View in: PubMed   Mentions: 75     Fields:    Translation:HumansAnimals
    150. Pharmacokinetics and tumor retention of 125I-labeled RGD peptide are improved by PEGylation. Nucl Med Biol. 2004 Jan; 31(1):11-9. Chen X, Park R, Shahinian AH, Bading JR, Conti PS. PMID: 14741566.
      View in: PubMed   Mentions: 47     Fields:    Translation:Animals
    151. FDG PET in suspected recurrent and metastatic prostate cancer. Oncol Rep. 2003 Sep-Oct; 10(5):1485-8. Jadvar H, Pinski JK, Conti PS. PMID: 12883728.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    152. Kinetic modeling of 5-fluorouracil anabolism in colorectal adenocarcinoma: a positron emission tomography study in rats. Cancer Res. 2003 Jul 01; 63(13):3667-74. Bading JR, Yoo PB, Fissekis JD, Alauddin MM, D'Argenio DZ, Conti PS. PMID: 12839957.
      View in: PubMed   Mentions: 6     Fields:    Translation:Animals
    153. Receptor mediated uptake of a radiolabeled contrast agent sensitive to beta-galactosidase activity. Nucl Med Biol. 2003 Apr; 30(3):261-5. Alauddin MM, Louie AY, Shahinian A, Meade TJ, Conti PS. PMID: 12745017.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimals
    154. Diagnostic utility of FDG PET in multiple myeloma. Skeletal Radiol. 2002 Dec; 31(12):690-4. Jadvar H, Conti PS. PMID: 12483429.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    155. Incidental colonic fluorodeoxyglucose uptake: correlation with colonoscopic and histopathologic findings. Radiology. 2002 Sep; 224(3):783-7. Tatlidil R, Jadvar H, Bading JR, Conti PS. PMID: 12202714.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    156. Comparison of radiolabeled nucleoside probes (FIAU, FHBG, and FHPG) for PET imaging of HSV1-tk gene expression. J Nucl Med. 2002 Aug; 43(8):1072-83. Tjuvajev JG, Doubrovin M, Akhurst T, Cai S, Balatoni J, Alauddin MM, Finn R, Bornmann W, Thaler H, Conti PS, Blasberg RG. PMID: 12163634.
      View in: PubMed   Mentions: 66     Fields:    Translation:AnimalsCells
    157. Evaluation of 2'-deoxy-2'-flouro-5-methyl-1-beta-D-arabinofuranosyluracil as a potential gene imaging agent for HSV-tk expression in vivo. Mol Imaging. 2002 Apr-Jun; 1(2):74-81. Alauddin MM, Shahinian A, Gordon EM, Conti PS. PMID: 12920847.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    158. Administration guidelines for radioimmunotherapy of non-Hodgkin's lymphoma with (90)Y-labeled anti-CD20 monoclonal antibody. J Nucl Med. 2002 Feb; 43(2):267-72. Wagner HN, Wiseman GA, Marcus CS, Nabi HA, Nagle CE, Fink-Bennett DM, Lamonica DM, Conti PS. PMID: 11850494.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    Peter's Networks
    Concepts (556)
    Derived automatically from this person's publications.
    _
    Co-Authors (72)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _